Grippe

Kissling,E., Valenciano, M., Pozo, F., Vilcu, A.-M., Reuss, A., Rizzo, C., Larrauri, A.,Horváth, J. K., Brytting, M., Domegan, L., Korczyńska, M., Meijer, A., Machado,A., Ivanciuc, A., Višekruna Vučina, V., van der Werf, S., Schweiger, B., Bella,A., Gherasim, A., Ferenczi, A., Zakikhany, K., O′Donnell, J., Paradowska-Stankiewicz,I., Dijkstra, F., Guiomar, R., Lazar, M., Kurečić Filipović, S., Johansen, K.,Moren, A. and I-MOVE/I-MOVE+ study team (), 2015/16 I-MOVE/I-MOVE+ multicenter case control study in Europe: moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage mismatched influenza B among children. Influenza Other Respi Viruses. 2018 Jul;12(4):423-437. doi: 10.1111/irv.12520 Valenciano M, Kissling E, Larrauri A, Nunes B, Pitigoi D, O Donnell J, Reuss A, Horváth JK, Paradowska-Stankiewicz I, Rizzo C, Falchi A, Daviaud I, Brytting M, Meijer A, Kaic B, Gherasim A, Machado A, Ivanciuc A, Domegan L, Schweiger B, Ferenczi A, Korczyńska M, Bella A, Vilcu AM, Mosnier A, Zakikhany K, Filipovićović SK, de Lange M.Johansen K, Moren A, I-MOVE primary care multicentre case-control team. Exploring the effect of previous inactivated influenza vaccination on seasonal influenza vaccine effectiveness against medically-attended influenza: results of the European I-MOVE multicentre test-negative case-control study, 2011/12-2016/17. Influenza Other Respir Viruses. 2018;1-15.doi: 10.1111/irv.12562. Rondy Marc, Kissling Esther, Emborg Hanne-Dorthe, Gherasim Alin, Pebody Richard, Trebbien Ramona, Pozo Francisco, Larrauri Amparo,McMenamin Jim, Valenciano Marta, I-MOVE/I-MOVE+ group. Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies. Euro Surveill. 2018;23(9):pii=18-00086 Rondy M,Gherasim A, Casado I, Launay O,Rizzo C,Pitigoi D, Mickiene A, Marbus SD, Machado A,Syrjänen RK, Pem-Novose I, Horváth JK, Larrauri A, Castilla J, Vanhems P, Alfonsi V, Ivanciuc AE, Kuliese M,van Gageldonk-Lafeber Rl, Gomez V, Ikonen N, Lovric Z, Ferenczi A, I-MOVE+ hospital working group, Moren A: Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season. Euro Surveill. 2017;22(41):pii=17-00645. https://doi.org/10.2807/1560-7917.ES.2017.22.41.17-0064 Rondy M, Launay O, Castilla J, Costanzo S, Puig-Barberà J, Gefenaite G, Larrauri A, Rizzo C, Pitigoi D, Syrjänen RK, Machado A, Kurečić Filipović S, Krisztina Horváth J, Paradowska-Stankiewicz I, Marbus S; InNHOVE/I-MOVE+working group, Moren A. Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza. Vaccine. 2017 Jul 11. pii: S0264-410X(17)30896-4. doi: 10.1016/j.vaccine.2017.06.088. Kissling E, Rondy M, I-MOVE/I-MOVE+ study team. Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe. Euro Surveill. 2017;22(7):pii=30464. DOI:http://dx.doi.org/10.2807/1560-7917.ES.2017.22.7.30464 Valenciano M, Kissling E, Reuss A, Rizzo C, Gherasim A, Horváth J, Domegan L, Pitigoi D, Machado A, Paradowska-Stankiewicz I, Bella A, Larrauri A, Ferenczi A, Joan O´Donell, Lazar M, Pechirra P, Korczyńska M, Pozo F, Moren A, on behalf of the I-MOVE multicentre case–control team. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case–Control Study, Europe 2014/15. Euro Surveill. 2016;21(7):pii=30139. DOI: http://dx.doi.org/10.2807/1560-7917.ES.2016.21.7.30139 Moren A. Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013-14: Results from the InNHOVE network. Hum Vaccines Immunother. 2016 May 3;12(5):1217–1224. PMID: 27065000 Kissling E, Valenciano M. Early influenza vaccine effectiveness results 2015-16: I-MOVE multicentre case-control study. Euro Surveill. 2016;21(6):pii=30134. DOI: http://dx.doi.org/10.2807/1560-7917.ES.2016.21.6.30134 Kissling E, Nunes B, Robertson C, Valenciano M, Reuss A, Larrauri A, Cohen JM, Oroszi B, Rizzo C, Machado A, Pitigoi D, Domegan L, Paradowska-Stankiewicz I, Buchholz U, Gherasim A, Daviaud I, Horváth JK, Bella A, Lupulescu E, O´Donnell J, Korczyńska M, Moren A, I-MOVE case–control study team. I-MOVE multicentre case–control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination? Euro Surveill. 2016;21(16):pii=30201. Kurečić Filipović S, Gjenero-Margan I, Kissling E, Kaić B, Cvitković A. Influenza vaccine effectiveness estimates in Croatia in 2010-2011: a season with predominant circulation of A(H1N1)pdm09 influenza virus. Epidemiol Infect. 2015 Sep;143(12):2596-603. doi: 10.1017/S0950268814003677. Epub 2015 Jan 8. Rondy M, Launay O, Puig-Barberà J, Gefenaite G, Castilla J, de Gaetano Donati K, Galtier F, Hak E, Guevara M, Costanzo S; European hospital IVE network, Moren A. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals. Euro Surveill. 2015 Jan 15;20(2). pii: 21011. Erratum in: Euro Surveill. 2015;20(3). pii: 21015. Niesters, Hubert [added]. Valenciano M, Kissling E, Reuss A, Jiménez-Jorge S, et al. The European I-MOVE multicentre 2013-14 case control study.Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2). Vaccine. 2015 Jun 4;33(24):2813-22. doi: 10.1016/j.vaccine.2015.04.012 Kissling E, Valenciano M, Buchholz U, Larrauri A, et al. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. Euro Surveill. 2014 Feb 13;19(6). pii: 20701. Valenciano M, Kissling E, I-MOVE case–control study team. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case–control study, 2012/13. Euro Surveill. 2013;18(7):pii=20400. Kissling E, Valenciano M, Larrauri A, Oroszi B, Cohen JM, Nunes B, Pitigoi D, Rizzo C, Rebolledo J, Paradowska-Stankiewicz I, Jiménez-Jorge S, Horváth JK, Daviaud I, Guiomar R, Necula G, Bella A, O’Donnell J, Głuchowska M, Ciancio BC, Nicoll A, Moren A. (2013) Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case–control study. Euro Surveill. 2013;18(5):pii=20390 Valenciano M., Ciancio B.C. on behalf of the I-MOVE study team. I-MOVE: a European network to measure the effectiveness of influenza vaccines. Euro Surveill. 2012 Sep 27;17(39). Kissling E, Valenciano M, I-MOVE case–control studies team. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12. Euro Surveill. 2012 Apr 12;17(15). Kelly H, Valenciano M. Estimating the effect of influenza vaccines. Lancet Infect Dis. 2012 Jan 1;12(1):5-6. Kissling E, Valenciano M, I-MOVE case–control studies team. I-MOVE Multi-Centre Case Control Study 2010-11: Overall and Stratified Estimates of Influenza Vaccine Effectiveness in Europe. Plos-ONE. 2011 Nov 15; 6(11). Kissling E, Valenciano M; I-MOVE case-control studies team. Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study. Euro Surveill. 2011 Mar 17;16(11). Valenciano M., Kissling E., I-MOVE case–control studies team. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-10: results of the I-MOVE multicentre case-control study. PlosMed. 2011 Jan 11;8(1). Valenciano M., Kissling E., Ciancio BC., Moren A. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine. 2010 Oct 28;28(46). Savulescu C, Valenciano M, de Mateo S, Larrauri A. Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network-Pilot case-control studies using different control groups, 2008-2009 season, Spain. Vaccine. 2010 Apr 1;28(16). Kissling E., Valenciano M., Falcão JM. et al. I-MOVE towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9. Euro Surveill. 2009 Nov 5; 14(44). Valenciano M, Ciancio B, Moren A. First steps in the design of a system to monitor vaccine effectiveness during seasonal and pandemic influenza in EU/EEA Member States. Euro Surveill. 2008 Oct 23;13(43). Rondy M, Puig-Barbera J, Launay O, Duval X, Castilla J, Guevara M, Costanzo S, de Gaetano Donati K, Moren A. (2013) 2011-12 Seasonal Influenza Vaccines Effectiveness against Confirmed A(H3N2) Influenza Hospitalisation: Pooled Analysis from a European Network of Hospitals. A Pilot Study. Plos One 8: e59681 Protocol for hospital-based case control studies to measure seasonal influenza vaccine effectiveness against laboratory confirmed influenza hospitalisations across the European Union and European Economic area Member States. Prepared by Seyler T, Rondy M, Valenciano M, Moren A. V4.0. Nov 2012. Protocol for case-control studies to measure influenza vaccine effectiveness in the European Union and European Economic Area Member States. Prepared for ECDC by Kissling E, Moren A, Valenciano M. Nov 2009. Protocol for cohort database studies to measure influenza vaccine effectiveness in the European Union and European Economic Area Member States. Prepared for ECDC by Kissling E, Moren A, Valenciano M. Nov 2009. Protocol for cluster investigations to measure pandemic and seasonal vaccine effectiveness in the EU and EEA. Prepared for ECDC by Kissling E, Moren A, Valenciano M. Dec 2009. Protocol for measuring influenza vaccine effectiveness using the screening method in the European Union and European Economic Area member States. Prepared for ECDC by Savulescu C, Kissling E, Moren A, Valenciano M.  

Papillomavirus Humain

Measuring the effectiveness and the impact of HPV vaccination, Synthesis Document. Prepared for SPMSD by Halm A, Valenciano M, Moren A. Version 5. Jul 2010. Evaluating of the impact of Human Papillomavirus vaccination, Generic protocol for before-after comparison studies. Prepared for SPMSD by Halm A, Valenciano M, Moren A. Jun 2010. Evaluating the effectiveness of the Human Papillomavirus vaccine, Draft Generic Protocol for HPV vaccine effectiveness studies. Prepared for SPMSD by Savulescu C, Halm A, Valenciano M, Moren A. Jan 2011. Evaluating the effectiveness of quadrivalent vaccine against four type Human Papilloma Virus’ oral and oro-pharyngeal infections in French female university students. Prepared for SPMSD by Savulescu C, Valenciano M, Moren A. Oct 2010.

Rotavirus

Infections invasives à pneumocoque

European Centre for Disease Prevention and Control. Generic protocol on enhanced surveillance for invasive pneumococcal disease at the EU/EEA level. Stockholm: ECDC; 2018. Authors: Savulescu C, Hanquet G, Valenciano M, Moren A – Epiconcept

Hanquet G, Krizova P, Valentiner-Branth P, Ladhani SN, Nuorti JK, Lepoutre A, Mereckiene J, Knol M, Winje BA, Ciruela P, Ordobas M, Guevara M, McDonald E, Morfeldt E, Kozakova J, Slotved HC, Fry NK, Rinta-Kokko H, Varon E, Corcoran M, van der Ende A, Vestrheim DF, Munoz-Almagro C, Latasa P, Castilla J, Smith A, Henriques-Normark B, Whittaker R, Pastore Celentano L, Savulescu C. and SpIDnet/I-MOVE+ pneumo group. Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of ten European countries. Implications for adult vaccination. Accepted for publication in Thorax Savulescu C, Krizova P, Lepoutre A, Mereckiene J, Vestrheim DF, Ciruela P, Ordobas M, Guevara M, McDonald E, Morfeldt E, Kozakova J, Varon E, Cotter S, Winje BA, Munoz-Almagro C, Garcia L, Castilla J, Smith A, Henriques-Normark B, Celentano LP, Hanquet G; SpIDnet group. Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study. Lancet Respir Med. 2017 Mar 27. pii: S2213-2600(17)30110-8. doi: 10.1016/S2213-2600(17)30110-8.

Maladie à virus Ebola

Exposure Patterns Driving Ebola Transmission in West Africa: A Retrospective Observational Study. PLoS Med. 2016 Nov 15;13(11):e1002170. doi: 10.1371/journal.pmed.1002170. eCollection 2016 Nov. Rico A, Brody D, Coronado F, Rondy M, Fiebig L, Carcelen A, Deyde VM, Mesfin S, Retzer KD, Bilivogui P, Keita S, Dahl BA. Epidemiology of Epidemic Ebola Virus Disease in Conakry and Surrounding Prefectures, Guinea, 2014-2015. Emerg Infect Dis. 2016 Feb;22(2):178-83. doi: 10.3201/eid2202.151304. Dixon MG, Taylor MM, Dee J, Hakim A, Cantey P, Lim T, Bah H, Camara SM, Ndongmo CB, Togba M, Touré LY, Bilivogui P, Sylla M, Kinzer M, Coronado F, Tongren JE, Swaminathan M, Mandigny L, Diallo B, Seyler T, Rondy M, Rodier G, Perea WA, Dahl B. Contact Tracing Activities during the Ebola Virus Disease Epidemic in Kindia and Faranah, Guinea, 2014. Emerg Infect Dis. 2015 Nov;21(11):2022-8. doi: 10.3201//eid2111.150684.

Meningitis

Rondy M, Issifou D, Ibrahim AS, Maman Z, Kadade G, Omou H, Fati S, Kissling E, Meyer S, Ronveaux O. Vaccine Effectiveness of Polysaccharide Vaccines Against Clinical Meningitis - Niamey, Niger, June 2015. PLoS Curr. 2016 Apr 18;8. pii: ecurrents.outbreaks.5d6e9c1d071a2088109c242771b68886. doi: 10.1371/currents.outbreaks.5d6e9c1d071a2088109c242771b68886.

Urgences complexes - Surveillance

Valenciano M, Moren A: Communicable disease surveillance in complex emergenciesInfectious Disease Surveillance 2nd edition, Wiley-Blackwell, London, United Kingdom, 2013 Santa-Olalla P, Gayer M, Magloire R, Barrais R, Valenciano M, Aramburu C et al. Implementation of an Alert and Response System in Haiti during the Early Stage of the Response to the Cholera Epidemic. Am J Trop Med Hyg. 2013; 89:688-697 Brown V, Guerin PJ, Legros D, Paquet C, Pécoul B, Moren A. Research in complex humanitarian emergencies: the Médecins Sans Frontières/Epicentre experience. PLoS Med. 2008 Apr 15;5(4).  

Autres

Halm A, Seyler T, Mohamed S, Ali Mbaé SB, Randrianarivo-Solofoniaina AE, Ratsitorahina M, Nundlall R, Aboobakar S, Bibi J, Filleul L, Piola P, Razafimandimby H, Rasamoelina H, Valenciano M, Moren A, Cardinale E, Lepec R, Flachet L. Four years into the Indian ocean field epidemiology training programme. Pan Afr Med J. 2017 Apr 4;26:195. doi: 10.11604/pamj.2017.26.195.10358

Krause G, Stefanoff P, Moren A. Applied epidemiology training in Europe: quite a success - but more to be done. Euro Surveill. 2009 Oct 29;14(43).

Hanquet G, Valenciano M, Simondon F, Moren A. Vaccine effects and impact of vaccination programmes in post-licensure studies. Vaccine 2013;31: 5434-42

Le Polain de Waroux O, Maguire H, Moren A. The case-cohort design in outbreak investigations. Euro Surveill. 2012 Jun 21;17(25). pii: 20202.

Checklist for reviewing protocols of observational epidemiological studies. Preparé pour SPMSD par Halm A, Valenciano M, Moren A. Version 5.2. Sep 2012.